Pharmacokinetic Variability and Target Attainment of Fluconazole in Critically Ill Patients

Suboptimal dosing of fluconazole in critically ill patients – time to rethink dosing

(2020) Eline W. Muilwijk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients

(2020) Matthias Gijsen et al.   CRITICAL CARE MEDICINE

Optimization of fluconazole dosing for the prevention and treatment of invasive candidiasis based on the pharmacokinetics of fluconazole in critically-ill patients

(2020) J. M. Boonstra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

(2019) Ignacio Martin-Loeches et al.   INTENSIVE CARE MEDICINE

Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients

(2016) Abdulaziz S. Alobaid et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort

(2016) L.E. López-Cortés et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach

(2016) Katherine N. Gharibian et al.   CLINICAL NEPHROLOGY

Epidemiology and reporting of candidaemia in Belgium: a multi-centre study

(2016) C. Trouvé et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome

(2016) M. Mansour Ceesay et al.   MEDICAL MYCOLOGY

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Insufficient Fluconazole Exposure in Pediatric Cancer Patients and the Need for Therapeutic Drug Monitoring in Critically Ill Children

(2014) Kim C. M. van der Elst et al.   CLINICAL INFECTIOUS DISEASES

Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis

(2014) F. Pea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Can the difference in serum concentration of urea and cystatin C be used in diagnosis and prognosis of heart failure?

(2014) Ante Matana et al.   MEDICAL HYPOTHESES

Fluconazole Pharmacokinetics in a Morbidly Obese, Critically Ill Patient Receiving Continuous Venovenous Hemofiltration

(2014) Natasha D. Lopez et al.   PHARMACOTHERAPY

Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection

(2014) V. Mistretta et al.   ACTA CLINICA BELGICA

Introduction to Drug Pharmacokinetics in the Critically III Patient

(2012) Brian S. Smith et al.   CHEST

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

(2012) O.A. Cornely et al.   CLINICAL MICROBIOLOGY AND INFECTION

Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets

(2011) Kashyap Patel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study

(2011) Guillaume Leroy et al.   Annals of Intensive Care

Fluconazole Dosing for the Prevention or Treatment of Invasive Candidiasis in Young Infants

(2010) Kelly C. Wade et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL